To test this, we used CRISPR-mediated gene editing to introduce biallelic inactivating mutations into USP13 in both HCT116 cells and HeLa cells (see Experimental Procedures for details), two human cancer cell lines with wildtype cohesin genes, and intact sister chromatid cohesion. This evidence concerns the gene USP13 and cancer.